Synlogic, Roche in Bowel-Disease Collaboration
June 17 2021 - 8:02AM
Dow Jones News
By Matt Grossman
Synlogic Inc. and Roche Holding AG will collaborate on research
into a treatment for inflammatory bowel disease, Synlogic said
Thursday.
Following the research period established by the agreement,
Roche will have an exclusive option for a licensing and
collaboration agreement for further development and
commercialization, according to Synlogic, a Cambridge, Mass. based
pharmaceutical company.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
June 17, 2021 07:56 ET (11:56 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
